Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05464992

Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRI

Led by Centre Paul Strauss · Updated on 2026-02-02

800

Participants Needed

1

Research Sites

730 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Standard Magnetic Resonance Imaging (MRI) is based on the excitation of hydrogen nuclei that are presents in water molecules, which abundance in human body allows for obtention of superior contrast. However, assessing the presence of other molecules than water in tissues is also of great clinical interest to probe metabolites related to physiological body function and pathological conditions. Chemical exchange saturation transfer (CEST) allow to overcome some limitations of proton magnetic resonance spectroscopy (1H-MRS) by exploiting chemical properties of the targeted molecule through a continuous process of re-saturation and exchange, and thus detecting it with increased sensitivity, from two orders of magnitude. Moreover, CEST technique is based on imaging sequences and can therefore benefit from well-known fast acquisition strategies, as well as improved spatial resolution.

CONDITIONS

Official Title

Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRI

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients admitted for a PET/MRI exam for preoperative evaluation of a cerebral expansion lesion
  • Patients undergoing evaluation of glioma recurrences
  • Patients undergoing evaluation of brain metastases
  • Patients undergoing evaluation of recurrence of metastases
Not Eligible

You will not qualify if you...

  • Contraindication to MRI
  • Minors or patients under guardianship or supervision
  • Patients deprived of liberty
  • Patients under judicial protection
  • Patients unable to give consent
  • Pregnant or breastfeeding women

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

France Institut de cancérologie Strasbourg Europe

Strasbourg, France

Actively Recruiting

Loading map...

Research Team

M

Manon VOEGELIN

CONTACT

C

Claire VIT

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here